Paper24453046
Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
Xu X and 5 others. J Cell Biochem, 2014. Cited by 39 papers, by iCite.
Cite this record
ConductScience Library. Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell. Papers, record 24453046. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24453046
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Membrane Proteins | Major topic |
| Prostatic Neoplasms | Major topic |
| Sphingosine N-Acyltransferase | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Animals | |
| Apoptosis | |
| Base Sequence | |
| Cell Cycle | |
| Cell Line, Tumor | |
| Gene Silencing | |
| Humans | |
| Male | |
| Matrix Metalloproteinase 2 | |
| Matrix Metalloproteinase 9 | |
| Mice | |
| Mice, Nude | |
| Molecular Sequence Data | |
| Neoplasm Invasiveness | |
| RNA, Small Interfering | |
| Vacuolar Proton-Translocating ATPases | |
| Xenograft Model Antitumor Assays |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42878017 | CerS2-mediated lipotoxicity and calcium signaling: a novel sequential mechanism of apoptosis in cancer. | Biochem J | 2026 | https://conductscience.org/library/papers/42878017 | PubMed |
| 41399074 | [Effect of dephosphorylation of tumor metastasis suppressor gene LASS2 on vacuolar ATPase activity and invasiveness of prostate cancer]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/41399074 | PubMed |
| 40305217 | A Map of the Lipid-Metabolite-Protein Network to Aid Multi-Omics Integration. | Biomolecules | 2025 | https://conductscience.org/library/papers/40305217 | PubMed |
| 39361104 | RBM15B Promotes Prostate Cancer Cell Proliferation via PCNA m6A Modification. | Cell Biochem Biophys | 2025 | https://conductscience.org/library/papers/39361104 | PubMed |
| 37958652 | The Role of Longevity Assurance Homolog 2/Ceramide Synthase 2 in Bladder Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958652 | PubMed |
| 37760612 | Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37760612 | PubMed |
| 36946034 | [LASS2/TMSG1 overexpression inhibits proliferation and promotes apoptosis of human lung cancer A549 cells possibly by upregulating ceramide and p38 MAPK to activate a signaling cascade]. | Nan Fang Yi Ke Da Xue Xue Bao | 2023 | https://conductscience.org/library/papers/36946034 | PubMed |
| 35504950 | The V-ATPases in cancer and cell death. | Cancer Gene Ther | 2022 | https://conductscience.org/library/papers/35504950 | PubMed |
| 34043125 | MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2. | Mol Cell Biochem | 2021 | https://conductscience.org/library/papers/34043125 | PubMed |
| 33568634 | Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33568634 | PubMed |
| 33396945 | Remodeling Lipids in the Transition from Chronic Liver Disease to Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33396945 | PubMed |
| 32776252 | Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer. | Rev Physiol Biochem Pharmacol | 2022 | https://conductscience.org/library/papers/32776252 | PubMed |
| 30988071 | Clinical and pathological significance of Homo sapiens ceramide synthase 2 (CerS-2) in diverse human cancers. | Biosci Rep | 2019 | https://conductscience.org/library/papers/30988071 | PubMed |
| 30537159 | High expression of LASS2 is associated with unfavorable prognosis in patients with ovarian cancer. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30537159 | PubMed |
| 30302058 | Overexpression of LASS2 inhibits proliferation and causes G0/G1 cell cycle arrest in papillary thyroid cancer. | Cancer Cell Int | 2018 | https://conductscience.org/library/papers/30302058 | PubMed |
| 29926527 | Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer. | Cancer Med | 2018 | https://conductscience.org/library/papers/29926527 | PubMed |
| 29731990 | Ceramide species are elevated in human breast cancer and are associated with less aggressiveness. | Oncotarget | 2018 | https://conductscience.org/library/papers/29731990 | PubMed |
| 29581781 | LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells. | J Cancer | 2018 | https://conductscience.org/library/papers/29581781 | PubMed |
| 29113153 | The role of LASS2 in regulating bladder cancer cell tumorigenicity in a nude mouse model. | Oncol Lett | 2017 | https://conductscience.org/library/papers/29113153 | PubMed |
| 29038303 | F-actin reorganization by V-ATPase inhibition in prostate cancer. | Biol Open | 2017 | https://conductscience.org/library/papers/29038303 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CERS2 | 29956 | PubTator's text mining | https://conductscience.org/library/genes/29956 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24453046
GET https://conductscience.org/api/papers/v1/24453046/cited_by?page=2